Pregabalin vs placebo at end of treatment
Dizziness · patients with fibromyalgia
Pregabalin leads to higher dizziness reported to be an adverse event compared with placebo at end of treatment (high certainty).
1 finding from 1 review
- RR 3.77 [3.06, 4.63]5 studies · 3257 participantsHigh